Veterinary Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Veterinary Molecular Diagnostics Market

4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, 2017-2031

5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry

6. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Product Type
    6.1. Introduction and Definitions
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Instruments & Software
        6.3.2. Kits & Reagents
        6.3.3. Services
    6.4. Market Attractiveness, by Product Type

7. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Technology
    7.1. Introduction and Definitions
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Technology, 2017–2031
        7.3.1. Conventional PCR
        7.3.2. Singleplex PCR
        7.3.3. Multiplex PCR
        7.3.4. Real-time PCR
        7.3.5. Others
        7.3.6. 7.4 Market Attractiveness, by Technology

8. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, By Disease Type
    8.1. Introduction and Definitions
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, By Disease Type, 2017–2031
        8.3.1. Vector-borne Diseases
        8.3.2. Respiratory Pathogens
        8.3.3. Diarrhea Pathogens
        8.3.4. Others
    8.4. Market Attractiveness, By Disease Type

9. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Animal Type
    9.1. Introduction and Definitions
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by Animal Type, 2017–2031
        9.3.1. Companion Animal
        9.3.2. Livestock Animal
    9.4. Market Attractiveness, by Animal Type

10. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by End-user
    10.1. Introduction and Definitions
    10.2. Key Findings/Developments
    10.3. Market Value Forecast, by End-user, 2017–2031
        10.3.1. Hospitals/Clinics
        10.3.2. Reference Laboratories
    10.4. Market Attractiveness, by End-user

11. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Region
    11.1. Key Findings
    11.2. Market Value Forecast, by Region, 2017–2031
        11.2.1. North America
        11.2.2. Europe
        11.2.3. Asia Pacific
        11.2.4. Latin America
        11.2.5. Middle East & Africa
    11.3. Market Attractiveness, by Region

12. North America Veterinary Molecular Diagnostics Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Instruments & Software
        12.2.2. Kits & Reagents
        12.2.3. Services
    12.3. Market Attractiveness, by Product Type
    12.4. Market Value Forecast, by Technology, 2017–2031
        12.4.1. Conventional PCR
        12.4.2. Singleplex PCR
        12.4.3. Multiplex PCR
        12.4.4. Real-time PCR
        12.4.5. Others
    12.5. Market Attractiveness, by Technology
    12.6. Market Value Forecast, By Disease Type, 2017–2031
        12.6.1. Vector-borne Diseases
        12.6.2. Respiratory Pathogens
        12.6.3. Diarrhea Pathogens
        12.6.4. Others
    12.7. Market Attractiveness, By Disease Type
    12.8. Market Value Forecast, by Animal Type, 2017–2031
        12.8.1. Companion Animal
        12.8.2. Livestock Animal
    12.9. Market Attractiveness, by Animal Type
    12.10. Market Value Forecast, by User End-user, 2017–2031
        12.10.1. Hospitals/Clinics
        12.10.2. Reference Laboratories
    12.11. Market Attractiveness, by End-user
    12.12. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.12.1. U.S.
        12.12.2. Canada
    12.13. Market Attractiveness Analysis
        12.13.1. By Product Type
        12.13.2. By Technology
        12.13.3. By Disease Type
        12.13.4. By Animal Type
        12.13.5. By End-user
        12.13.6. By Country

13. Europe Veterinary Molecular Diagnostics Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Instruments & Software
        13.2.2. Kits & Reagents
        13.2.3. Services
    13.3. Market Attractiveness, by Product Type
    13.4. Market Value Forecast, by Technology, 2017–2031
        13.4.1. Conventional PCR
        13.4.2. Singleplex PCR
        13.4.3. Multiplex PCR
        13.4.4. Real-time PCR
        13.4.5. Others
    13.5. Market Attractiveness, by Technology
    13.6. Market Value Forecast, By Disease Type, 2017–2031
        13.6.1. Vector-borne Diseases
        13.6.2. Respiratory Pathogens
        13.6.3. Diarrhea Pathogens
        13.6.4. Others
    13.7. Market Attractiveness, By Disease Type
    13.8. Market Value Forecast, by Animal Type, 2017–2031
        13.8.1. Companion Animal
        13.8.2. Livestock Animal
    13.9. Market Attractiveness, by Animal Type
    13.10. Market Value Forecast, by User End-user, 2017–2031
        13.10.1. Hospitals/Clinics
        13.10.2. Reference Laboratories
    13.11. Market Attractiveness, by End-user
    13.12. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.12.1. Germany
        13.12.2. U.K.
        13.12.3. France
        13.12.4. Italy
        13.12.5. Spain
        13.12.6. Rest of Europe
    13.13. Market Attractiveness Analysis
        13.13.1. By Product Type
        13.13.2. By Technology
        13.13.3. By Disease Type
        13.13.4. By Animal Type
        13.13.5. By End-user
        13.13.6. By Country/Sub-region
14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017–2031
        14.2.1. Instruments & Software
        14.2.2. Kits & Reagents
        14.2.3. Services
    14.3. Market Attractiveness, by Product Type
    14.4. Market Value Forecast, by Technology, 2017–2031
        14.4.1. Conventional PCR
        14.4.2. Singleplex PCR
        14.4.3. Multiplex PCR
        14.4.4. Real-time PCR
        14.4.5. Others
    14.5. Market Attractiveness, by Technology
    14.6. Market Value Forecast, By Disease Type, 2017–2031
        14.6.1. Vector-borne Diseases
        14.6.2. Respiratory Pathogens
        14.6.3. Diarrhea Pathogens
        14.6.4. Others
    14.7. Market Attractiveness, By Disease Type
    14.8. Market Value Forecast, by Animal Type, 2017–2031
        14.8.1. Companion Animal
        14.8.2. Livestock Animal
    14.9. Market Attractiveness, by Animal Type
    14.10. Market Value Forecast, by User End-user, 2017–2031
        14.10.1. Hospitals/Clinics
        14.10.2. Reference Laboratories
    14.11. Market Attractiveness, by End-user
    14.12. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.12.1. China
        14.12.2. Japan
        14.12.3. India
        14.12.4. Australia & New Zealand
        14.12.5. Rest of Asia Pacific
    14.13. Market Attractiveness Analysis
        14.13.1. By Product Type
        14.13.2. By Technology
        14.13.3. By Disease Type
        14.13.4. By Animal Type
        14.13.5. By End-user
        14.13.6. By Country/Sub-region
15. Latin America Veterinary Molecular Diagnostics Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Product Type, 2017–2031
        15.2.1. Instruments & Software
        15.2.2. Kits & Reagents
        15.2.3. Services
    15.3. Market Attractiveness, by Product Type
    15.4. Market Value Forecast, by Technology, 2017–2031
        15.4.1. Conventional PCR
        15.4.2. Singleplex PCR
        15.4.3. Multiplex PCR
        15.4.4. Real-time PCR
        15.4.5. Others
    15.5. Market Attractiveness, by Technology
    15.6. Market Value Forecast, By Disease Type, 2017–2031
        15.6.1. Vector-borne Diseases
        15.6.2. Respiratory Pathogens
        15.6.3. Diarrhea Pathogens
        15.6.4. Others
    15.7. Market Attractiveness, By Disease Type
    15.8. Market Value Forecast, by Animal Type, 2017–2031
        15.8.1. Companion Animal
        15.8.2. Livestock Animal
    15.9. Market Attractiveness, by Animal Type
    15.10. Market Value Forecast, by User End-user, 2017–2031
        15.10.1. Hospitals/Clinics
        15.10.2. Reference Laboratories
    15.11. Market Attractiveness, by End-user
    15.12. Market Value Forecast, by Country/Sub-region, 2017–2031
        15.12.1. Brazil
        15.12.2. Mexico
        15.12.3. Rest of Latin America
    15.13. Market Attractiveness Analysis
        15.13.1. By Product Type
        15.13.2. By Technology
        15.13.3. By Disease Type
        15.13.4. By Animal Type
        15.13.5. By End-user
        15.13.6. By Country/Sub-region

16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis and Forecast
    16.1. Introduction
        16.1.1. Key Findings
    16.2. Market Value Forecast, by Product Type, 2017–2031
        16.2.1. Instruments & Software
        16.2.2. Kits & Reagents
        16.2.3. Services
    16.3. Market Attractiveness, by Product Type
    16.4. Market Value Forecast, by Technology, 2017–2031
        16.4.1. Conventional PCR
        16.4.2. Singleplex PCR
        16.4.3. Multiplex PCR
        16.4.4. Real-time PCR
        16.4.5. Others
    16.5. Market Attractiveness, by Technology
    16.6. Market Value Forecast, By Disease Type, 2017–2031
        16.6.1. Vector-borne Diseases
        16.6.2. Respiratory Pathogens
        16.6.3. Diarrhea Pathogens
        16.6.4. Others
    16.7. Market Attractiveness, By Disease Type
    16.8. Market Value Forecast, by Animal Type, 2017–2031
        16.8.1. Companion Animal
        16.8.2. Livestock Animal
    16.9. Market Attractiveness, by Animal Type
    16.10. Market Value Forecast, by User End-user, 2017–2031
        16.10.1. Hospitals/Clinics
        16.10.2. Reference Laboratories
    16.11. Market Attractiveness, by End-user
    16.12. Market Value Forecast, by Country/Sub-region, 2017–2031
        16.12.1. GCC Countries
        16.12.2. South Africa
        16.12.3. Rest of Middle East & Africa
    16.13. Market Attractiveness Analysis
        16.13.1. By Product Type
        16.13.2. By Technology
        16.13.3. By Disease Type
        16.13.4. By Animal Type
        16.13.5. By End-user
        16.13.6. By Country/Sub-region

17. Competition Landscape
    17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
    17.2. Market Share Analysis, by Company (2022)
    17.3. Company Profiles
        17.3.1. IDEXX Laboratories, Inc.
            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.1.2. Product Portfolio
            17.3.1.3. Financial Overview
            17.3.1.4. SWOT Analysis
            17.3.1.5. Strategic Overview
        17.3.2. Thermo Fisher Scientific, Inc.
            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.2.2. Product Portfolio
            17.3.2.3. Financial Overview
            17.3.2.4. SWOT Analysis
            17.3.2.5. Strategic Overview
        17.3.3. Zoetis, Inc.
            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.3.2. Product Portfolio
            17.3.3.3. Financial Overview
            17.3.3.4. SWOT Analysis
            17.3.3.5. Strategic Overview
        17.3.4. Neogen Corporation
            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.4.2. Product Portfolio
            17.3.4.3. Financial Overview
            17.3.4.4. SWOT Analysis
            17.3.4.5. Strategic Overview
        17.3.5. bioM?rieux SA
            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.5.2. Product Portfolio
            17.3.5.3. Financial Overview
            17.3.5.4. SWOT Analysis
            17.3.5.5. Strategic Overview
        17.3.6. QIAGEN N.V.
            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.6.2. Product Portfolio
            17.3.6.3. Financial Overview
            17.3.6.4. SWOT Analysis
            17.3.6.5. Strategic Overview
        17.3.7. Biomedica Medizinprodukte GmbH
            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.7.2. Product Portfolio
            17.3.7.3. Financial Overview
            17.3.7.4. SWOT Analysis
            17.3.7.5. Strategic Overview
        17.3.8. Bioneer
            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.8.2. Product Portfolio
            17.3.8.3. Financial Overview
            17.3.8.4. SWOT Analysis
            17.3.8.5. Strategic Overview
        17.3.9. Mars, Incorporated
            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.9.2. Product Portfolio
            17.3.9.3. Financial Overview
            17.3.9.4. SWOT Analysis
            17.3.9.5. Strategic Overview
        17.3.10. Innovative Diagnostics
            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.10.2. Product Portfolio
            17.3.10.3. Financial Overview
            17.3.10.4. SWOT Analysis
            17.3.10.5. Strategic Overview

List of Figures

List of Figures

Figure 01: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Product Type, 2022

Figure 03: Global Veterinary Molecular Diagnostics Market Value Share, by Product Type, 2022

Figure 04: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Technology, 2022

Figure 05: Global Veterinary Molecular Diagnostics Market Value Share, by Technology, 2022

Figure 06: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), By Disease Type, 2022

Figure 07: Global Veterinary Molecular Diagnostics Market Value Share, By Disease Type, 2022

Figure 08: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Animal Type, 2022

Figure 09: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2022

Figure 10: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2022

Figure 11: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2022

Figure 12: Global Veterinary Molecular Diagnostics Market Value Share, by Region, 2022

Figure 13: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

Figure 14: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031

Figure 15: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031

Figure 16: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031

Figure 17: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031

Figure 18: Global Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031

Figure 19: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031

Figure 20: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Animal Type, 2022

Figure 21: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2022

Figure 22: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2022

Figure 23: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2022

Figure 24: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Region, 2022–2031

Figure 25: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Region, 2023-2031

Figure 26: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 27: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country, 2023–2031

Figure 28: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Country, 2022–2031

Figure 29: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031

Figure 30: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031

Figure 31: North America Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031

Figure 32: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031

Figure 33: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031

Figure 34: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 35: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031

Figure 36: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031

Figure 37: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031

Figure 38: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 39: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 40: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 41: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 42: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031

Figure 43: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031

Figure 44: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031

Figure 45: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031

Figure 46: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031

Figure 47: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 48: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031

Figure 49: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031

Figure 50: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031

Figure 51: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 52: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 53: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 54: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 55: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031

Figure 56: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031

Figure 57: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031

Figure 58: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031

Figure 59: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031

Figure 60: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 61: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031

Figure 62: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031

Figure 63: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031

Figure 64: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 65: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 66: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 67: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 68: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031

Figure 69: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031

Figure 70: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031

Figure 71: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031

Figure 72: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031

Figure 73: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 74: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031

Figure 75: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031

Figure 76: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031

Figure 77: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 78: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 79: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 80: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 81: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022–2031

Figure 82: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022–2031

Figure 83: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022–2031

Figure 84: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022–2031

Figure 85: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022–2031

Figure 86: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031

Figure 87: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023–2031

Figure 88: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023–2031

Figure 89: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023–2031

Figure 90: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

List of Tables

List of Tables

Table 01: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 03: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 04: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031

Table 05: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 09: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 10: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031

Table 11: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 12: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 15: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 16: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031

Table 17: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 18: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 19: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 21: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 22: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031

Table 23: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 24: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 28: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031

Table 29: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 30: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 31: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 32: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 33: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 34: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017–2031

Table 35: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 36: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031